Jacksonville is located just 30 miles from the state capital in Springfield, Illinois, and two hours from a major metropolitan area (St. Louis, Missouri).
Simply stated, Jacksonville and its surrounding area, is an excellent place to live and work. Jacksonville is a family-oriented town of quiet neighborhoods, modern subdivisions, and historic districts. The city has both strong public and parochial schools. In addition, Jacksonville is home to two liberal arts colleges and two state institutions. Jacksonville is also rich in culture, offering citizens a symphony orchestra, theater guild, and art gallery, plus numerous special events throughout the year.
Passavant Area Hospital, in collaboration with the Regional Cancer Center at Memorial Medical Center, is adding radiation therapy to its list of patient services.
Beginning in March 2017, cancer patients will receive radiation therapy treatments in the facility, located at 567 North Westgate, on the Passavant campus. This service will facilitate patients working with the clinical team at Regional Cancer Center at Memorial Medical Center to develop their individualized care plan. Once the plan has been created, the patient can receive their ongoing radiation treatment needs at Passavant Area Hospital.
“This approach provides greater access, ease and comfort for the patient during this very difficult time. They will have the support and availability of this service right here in Jacksonville, while working in partnership with the talented clinical staff of the Regional Cancer Center,” said Doug Rahn, president and chief executive officer at Passavant Area Hospital.
The facility will feature a new linear accelerator that will provide the latest technology in radiation therapy. Radiation therapy is the use of high-energy radiation to damage cancer cells’ DNA and destroy their ability to divide and grow. The radiation therapy is delivered via the accelerator or via radioactive sources placed inside the patient. Radiation therapy can also help reduce pain and suffering in patients with advanced cancer.